| Literature DB >> 21569626 |
Leandro P Moura1, Guilherme M Puga, Wladimir R Beck, Inaian P Teixeira, Ana Carolina Ghezzi, Gláucio A Silva, Maria Alice R Mello.
Abstract
BACKGROUND: Diabetes mellitus is associated with metabolic dysfunctions, including alterations in circulating lipid levels and fat tissue accumulation, which causes, among other pathologies, non-alcoholic fatty liver disease (NAFLD). AIM OF THE STUDY: The objective of this study was to analyse the effects of physical exercise and spirulina intake on the control of NAFLD in diabetic Wistar rats.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21569626 PMCID: PMC3112424 DOI: 10.1186/1476-511X-10-77
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Figure 1Mean and standard error of body mass - a; the difference between body mass pre- and post-intervention (Δ = variation of mass in relation to initial mass over time) - b; area under the curve of body mass over time of the body mass - c. DC - control group; DS - group with spirulina intake and without exercise; DSE - group with spirulina intake and with exercise; and DE - group without intake of spirulina and with exercise (10 animals/group).
Figure 2Mean and standard error of water consumption (a) and area under the curve (b) of all groups. Median values of food consumption (c) and the area under the curve (d) of all groups. DC - control group; DS - group with spirulina intake and without exercise; DSE - group with spirulina intake and with exercise; and DE - group without intake of spirulina and with exercise (10 animals/group).
Serum analysis at the end of the experiment.
| DC | DS | DSE | DE | |
|---|---|---|---|---|
| Total Cholesterol (mg.dL-1) | 108.8 (9.8) | 105.5 (4.9) | 94.3 (6.2) | 91.2 (4.0) |
| HDL - Cholesterol (mg.dL-1) | 19.8 (0.8) | 17.7 (0.7) | 15.7 (1.0)* | 18.4 (0.7) |
| LDL - Cholesterol (mg.dL-1) | 64.0 (7.3) | 42.2 (5.7)* | 37.4 (3.9)* | 52.2 (3.8) |
| Triglycerides (mg.dL-1) | 105.6 (9.9) | 237.2 (39.9) | 237.8 (46.4) | 112.7 (22.2) |
| Free Fatty Acids (mg.dL-1) | 0.66 (0.05) | 0.66 (0.06) | 0.62 (0.04) | 0.67 (0.04) |
| Albumin (mg%) | 2.61 (0.06) | 2.42 (0.02) | 2.28 (0.14)* | 2.56 (0.06) |
| Total Proteins (mg%) | 7.66 (0.36) | 7.19 (0.11) | 7.34 (0.32) | 7.47 (0.19) |
| Glucose (mg.dL-1) | 303.20 (70.69) | 289.25 (106.65) | 248.88 (84.92) | 275.40 (90.90) |
| Insulin (U.mL-1) | 1.64 (0.21) | 0.43 (0.21)* | 12.69 (3.24) | 9.73 ± 3.68 |
Results expressed with means and (standard errors) of 10 animals/group. DC: Diabetic Control, DS: Diabetic Spirulina, DSE: Diabetic Spirulina Exercise and DE: Diabetic Exercise. Statistical Difference (ANOVA p < 0.05), *= different from DC.
Tissue lipids analyses at the end of the experiment.
| DC | DS | DSE | DE | |
|---|---|---|---|---|
| Total Lipids (mg%) | 07.61 (1.52) | 04.15 (0.17)* | 04.24 (0.29)* | 04.36 (0.49)* |
| Triglycerides (mg%) | 18.52 (3.87) | 10.59 (1.05)* | 11.11 (1.32) | 12.12 (1.94) |
| Triglycerides (mg%) | 12.04 (1.60) | 08.82 (0.95) | 08.38 (0.84) | 09.17 (0.98) |
| Triglycerides (mg%) | 5.95 (0.59) | 07.07 (0.67) | 06.27 (0.59) | 6.43 (0.70) |
Results expressed with means and (standard errors) of 10 animals/group. DC: Diabetic Control, DS: Diabetic Spirulina, DSE: Diabetic Spirulina Exercise and DE: Diabetic Exercise. Statistical Difference (ANOVA p < 0.05), *= different from DC.